Blackwell Kimberly - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 1, 2024, Blackwell Kimberly's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Director,Officer (Chief Executive Officer), and currently has 504,800 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Blackwell Kimberly - Insider Non-Derivative Transactions of ZNTL Common Stock
Blackwell Kimberly - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 2, 2024 | F -- (Common Stock) | 20655 | 11.69 | 484145 |
| Feb 2, 2024 | Acquisition -- (Common Stock) | 250000 | 0 | 504800 |
| Nov 14, 2023 | P -- (Common Stock) | 5000 | 10.29 | 254800 |
| Feb 2, 2023 | Acquisition -- (Common Stock) | 244800 | 0 | 249800 |